APOL1, Black Race, and Kidney Disease: Turning Attention to Structural Racism

Am J Kidney Dis. 2021 Jun;77(6):857-860. doi: 10.1053/j.ajkd.2020.11.029. Epub 2021 Jan 22.

Authors

Jessica P Cerdeña¹, Jennifer Tsai², Vanessa Grubbs³

Affiliations

¹ Yale School of Medicine, New Haven, CT; Department of Anthropology, Yale University, New Haven, CT. Electronic address: jessica.cerdena@yale.edu.
² Department of Emergency Medicine, Yale School of Medicine, New Haven, CT.
³ Division of Nephrology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA.

PMID: 33485919
DOI: 10.1053/j.ajkd.2020.11.029

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Apolipoprotein L1 / genetics*
Apolipoprotein L1 / physiology
Black or African American / genetics*
Humans
Kidney Diseases / genetics*
Racism*

Substances

APOL1 protein, human
Apolipoprotein L1

Grants and funding

T32 GM136651/GM/NIGMS NIH HHS/United States